Please login to the form below

Not currently logged in
Email:
Password:

loxapine

This page shows the latest loxapine news and features for those working in and with pharma, biotech and healthcare.

Teva launches first inhaled antipsychotic in US

Teva launches first inhaled antipsychotic in US

Adasuve (loxapine) was originally developed by US company Alexza Pharmaceuticals and becomes the first and only inhaled antipsychotic drug for this indication in the US market. ... According to Teva, the delivery of loxapine using Alexza's proprietary

Latest news

  • EU approves Alexza’s antipsychotic Adasuve EU approves Alexza’s antipsychotic Adasuve

    Company plans to launch it in third quarter of 2013 in partnership with Grupo Ferrer

  • FDA panel backs Alexza’s inhaled antipsychotic drug

    Shares in Alexza climbed more than 70 per cent after the 9-8 vote by the Psychopharmacologic Drugs Advisory Committee (PDAC) improved the chances that Adasuve (loxapine delivered using Alexza's ... The speed of onset of treatment with inhaled loxapine is

  • Schizophrenia treatments

    The product uses the Alexza's Staccato hand-held, disposable inhaler technology which vaporises loxapine by heating a thin film of the agent. . ... Worldwide revenue projections for inhaled loxapine, cariprazine and TC 5619 are represented in figure

  • Alexza schizophrenia drug delayed

    Alexza said it had completed an end-of-review meeting with the FDA for Adusuve Staccato (loxapine) inhalation aerosol, which is being developed for the rapid treatment of agitation in schizophrenia

  • Alexza psychiatric drug delayed

    Alexza Pharmaceuticals has received a Complete Response Letter (CRL)  from the US Food and Drug Administration (FDA) voicing concerns about the safety of Adusuve Staccato (loxapine) inhalation aerosol.

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics